Physician profile
Maximillian Bourdillon
NPI 1215431838
$12,809.24
in general payments reported to CMS, 2019-2025
16 companies · $7,388 in 2025
The $7,388 reported for 2025 was more than what 93% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $1,613 · 2024: $3,809 · 2025: $7,388.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Grant: $7,000 · Food and Beverage: $4,212 · Travel and Lodging: $1,263 · Education: $335.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Grant | $7,000.00 |
| Food and Beverage | $4,211.60 |
| Travel and Lodging | $1,262.89 |
| Education | $334.75 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $7,494.59 | 2023-2025 | General - Atherectomy, Rotablator Rotational Atherectomy System Console Kit, Avvigo Guidance System |
| Medtronic, INC. | $2,471.81 | 2024-2025 | Resolute Onyx, Corevalve Evolut R |
| Edwards Lifesciences Corporation | $1,332.73 | 2024-2025 | Sapien 3 Ultra Resilia, Edwards Sapien 3 Ultra Transcatheter Heart Valve |
| Abiomed | $388.17 | 2024-2025 | Impella |
| Abbott Laboratories | $174.98 | 2025 | Perclose Prostyle, Triclip |
| Amgen INC. | $148.40 | 2024 | Repatha |
| Penumbra, INC. | $141.22 | 2024 | Indigo System |
| Inari Medical, INC. | $133.43 | 2023 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Teleflex LLC | $128.04 | 2025 | Turnpike, Arrow |
| Terumo Medical Corporation | $96.56 | 2024 | Tr Band, Glidesheath Slender, Heartrail |
| Pfizer INC. | $91.64 | 2023-2024 | |
| Cardiva Medical, INC. | $78.99 | 2025 | Optowire |
| Cook Medical LLC | $65.65 | 2025 | Zilver Ptx |
| Lexicon Pharmaceuticals, INC. | $24.06 | 2023 | Inpefa |
| Astrazeneca Pharmaceuticals LP | $20.41 | 2023 | Andexxa |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Scpharmaceuticals INC. | $18.56 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Maximillian Bourdillon listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.